A small number of people infected with HIV produce antibodies with an amazing effect: Not only are the antibodies directed against the own virus strain, but also against different sub-types of HIV ...

April 5, 2012 (SILVER SPRING, Md.) -- Researchers have discovered important clues about the immune responses that may have played a role in protecting some volunteers from HIV in the RV144 Thai trial.

Ever since the AIDS epidemic erupted nearly 40 years ago, researchers have tried to make a vaccine. The efforts typically end up like this: "Failure Of Latest HIV Vaccine Test: A 'Huge Disappointment.

However, in one of its first important findings, tree-building soon revealed two different types of HIV, now regarded as separate species. The first (particularly infective and virulent) type ...

Human immunodeficiency virus (HIV) infections are lifelong, potentially life-threatening infections that weaken an individual’s immune system, rendering them susceptible to severe secondary infections ...

The 900,000 new HIV infections among women globally in 2015 attest to the urgent need for the dissemination of effective new HIV-prevention products for women. Most women are infected with HIV by ...

Sample blood collection tube with HIV test label on HIV infection screening test form. (Photo credit: Shutterstock.com / Room's Studio) A non-reactive HIV test result generally means good news – you ...

A multi-institutional team led by Weill Cornell Medicine has received a five-year, $14.9 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes ...

HIV is a lifelong infection that affects many people. People with HIV take many different types of medicines to help control their condition and to prevent the infection from developing into AIDS.

Three weeks after Gilead filed its long-acting HIV drug for FDA approval, the new antiviral is padding its case. After six months, lenacapavir, along with other antiretroviral drugs, drove HIV down to ...

WASHINGTON (July 27, 2015) - The improved survival rate of HIV patients in sub-Saharan Africa due to effective treatment programs is increasing the ability of researchers in Africa to study the ...